Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics (Premium)
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Beijing Tiantan Biological Products Corp Ltd Announces FY 2013 H1 Net Profit Outlook


Monday, 29 Jul 2013 08:00pm EDT 

Beijing Tiantan Biological Products Corp Ltd announced that it expects its net profit for the first half of fiscal year (FY) 2013 to increase by 40% to 60%, compared to the net profit of the same period in FY 2012 (RMB 146.85 million). The Company cited the increased sales and effective cost and expense control as the main reason for the forecast. 

Company Quote